|
|||||
|
|
Vitamin D,osteoprotegerin/receptor activator of nuclear factor‐kappaB ligand (OPG/RANKL) and inflammation with alendronate treatment in HIV‐infected patients with reduced bone mineral density |
|
| Authors: | J Natsag MA Kendall DE Sellmeyer GA McComsey TT Brown |
| Affiliation: | 1. Division of Endocrinology, Diabetes & Metabolism, Johns Hopkins University, Baltimore, MD, USA;2. Center for Biostatistics in AIDS Research, Harvard School of Public Health, Boston, MA, USA;3. Metabolic Bone Center, Johns Hopkins Bayview Medical Center, Baltimore, MD, USA;4. Division of Pediatric Infectious and Rheumatology Diseases, Case Western Reserve University, Cleveland, OH, USA |
| Abstract: | |
| Keywords: | alendronate bone turnover marker inflammation low bone mineral density vitamin D |